Literature DB >> 11460516

Wound healing. Role of commercial fibrin sealants.

D L Amrani1, J P Diorio, Y Delmotte.   

Abstract

This paper focuses on the use of commercial fibrin sealant (FS) in specific wound healing applications. This review is not intended to be all inclusive, but to examine in vitro and in vivo models, as well as select clinical conditions that are representative of specific wound healing applications of FS.

Mesh：

Substances：

Year:  2001        PMID： 11460516

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  13 in total

1.  Quality of thrombin produced from the patient's own plasma using the TPD, a new Thrombin-processing Device.

Authors:  Elisabeth Semple; Trista Madsen; John W Semple
Journal:  J Extra Corpor Technol       Date:  2005-06

2.  Postinfarction Functional Recovery Driven by a Three-Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.

Authors:  Santiago Roura; Carolina Soler-Botija; Juli R Bagó; Aida Llucià-Valldeperas; Marco A Férnandez; Carolina Gálvez-Montón; Cristina Prat-Vidal; Isaac Perea-Gil; Jerónimo Blanco; Antoni Bayes-Genis
Journal:  Stem Cells Transl Med       Date:  2015-06-23       Impact factor: 6.940

3.  Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions.

Authors:  Stephan Reppenhagen; Johannes C Reichert; Lars Rackwitz; Maximilian Rudert; Peter Raab; Guy Daculsi; Ulrich Nöth
Journal:  Int Orthop       Date:  2011-05-28       Impact factor: 3.075

4.  Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch.

Authors:  Francisco M Martín-Saavedra; Christopher G Wilson; Richard Voellmy; Nuria Vilaboa; Renny T Franceschi
Journal:  Hum Gene Ther Methods       Date:  2013-05-06       Impact factor: 2.396

5.  Whole blood thrombin: development of a process for intra-operative production of human thrombin.

Authors:  Vijay Kumar; John R Chapman
Journal:  J Extra Corpor Technol       Date:  2007-03

6.  Autologous thrombin: intraoperative production from whole blood.

Authors:  Vijay Kumar; John R Chapman
Journal:  J Extra Corpor Technol       Date:  2008-06

7.  Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device.

Authors:  Vijay Kumar; Trista Madsen; Haihong Zhu; Elisabeth Semple
Journal:  J Extra Corpor Technol       Date:  2005-12

8.  Permeability of three-dimensional fibrin constructs corresponds to fibrinogen and thrombin concentrations.

Authors:  Cecilia L Chiu; Vivian Hecht; Haison Duong; Benjamin Wu; Bill Tawil
Journal:  Biores Open Access       Date:  2012-01

9.  Experimental comparison of type of Tissucol dilution and composite mesh (Parietex) for laparoscopic repair of groin and abdominal hernia: observational study conducted in a university laboratory.

Authors:  Stefano Olmi; Alessandro Addis; Cinzia Domeneghini; Alberto Scaini; Enrico Croce
Journal:  Hernia       Date:  2007-02-13       Impact factor: 2.920

10.  A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells.

Authors:  Antonella Lisi; Enrica Briganti; Mario Ledda; Paola Losi; Settimio Grimaldi; Rodolfo Marchese; Giorgio Soldani
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.